Black Rock Inc. Roivant Sciences Ltd. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Black Rock Inc. holds 35,370,270 shares of ROIV stock, worth $718 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,370,270

Previous 36,187,519 2.26%

Holding current value

$718 Million

Previous $381 Million 1.98%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$10.36 - $11.74 $8.47 Million - $9.59 Million	-817,249 Reduced 2.26%	35,370,270 $374 Million
Q1 2024 May 10, 2024	BUY	$9.87 - $11.8 $152 Million - $182 Million	15,381,918 Added 73.93%	36,187,519 $381 Million
Q4 2023 Feb 13, 2024	BUY	$8.38 - $11.58 $25.8 Million - $35.7 Million	3,082,064 Added 17.39%	20,805,601 $234 Million
Q3 2023 Nov 13, 2023	BUY	$9.76 - $13.19 $52.2 Million - $70.6 Million	5,350,664 Added 43.25%	17,723,537 $207 Million
Q2 2023 Aug 11, 2023	BUY	$7.09 - $10.08 $43.7 Million - $62.2 Million	6,170,264 Added 99.48%	12,372,873 $125 Million

Q1 2023 May 12, 2023	BUY	$6.92 - $9.98 $597,694 - $861,992	86,372 Added 1.41%	6,202,609 $45.8 Million
Q4 2022 Feb 13, 2023	BUY	$3.36 - $7.99 $2.69 Million - $6.39 Million	800,258 Added 15.05%	6,116,237 $48.9 Million
Q3 2022 Nov 14, 2022	SELL	$0.51 - $4.84 $57,160 - $542,462	-112,079 Reduced 2.06%	5,315,979 $17.1 Million
Q2 2022 Aug 12, 2022	BUY	$2.81 - $4.84 $3.89 Million - $6.7 Million	1,383,639 Added 34.21%	5,428,058 $22.1 Million
Q1 2022 May 12, 2022	BUY	$4.74 - $9.91 $556,139 - $1.16 Million	117,329 Added 2.99%	4,044,419 $20 Million
Q4 2021 Feb 10, 2022	BUY	$5.86 - $13.52 $23 Million - $53.1 Million	3,927,090 New	3,927,090 $39.6 Million

Others Institutions Holding ROIV

# of Institutions

374

Shares Held

436M

Call Options Held

6.05M

Put Options Held

2.52M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $14.3B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account